Glioblastoma
Glioblastoma is a highly aggressive brain tumor that arises from glial cells, leading to rapid growth and severe symptoms. It is known for its poor prognosis and can cause significant neurological impairment.
We are studying a new light-based treatment for adults with grade IV glioblastoma during surgery. The goal is to evaluate its safety and how well it works in reducing tumor response.
Health conditions and diseases that the clinical trial is designed to study and treat.
Glioblastoma is a highly aggressive brain tumor that arises from glial cells, leading to rapid growth and severe symptoms. It is known for its poor prognosis and can cause significant neurological impairment.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.